Invention Grant
- Patent Title: Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
-
Application No.: US16217612Application Date: 2018-12-12
-
Publication No.: US11644472B2Publication Date: 2023-05-09
- Inventor: Herbert Andres , Dirk Block , Johann Karl , Peter Kastner , Ursula-Henrike Wienhues-Thelen , Roberto Latini , Serge Masson , Andre Ziegler , Edelgard Kaiser , Stefan Palme , Markus Thomas , Simona Barlera
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Stinson LLP
- Priority: EP 174910 2016.06.17
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68
Abstract:
A method for predicting the risk of recurrence of Atrial Fibrillation in a subject based on measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject is described. Also described is a method of diagnosing Atrial Fibrillation in a subject suspected to suffer from Atrial Fibrillation based on measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. Also described are devices adapted to carry out the method of the present disclosure.
Public/Granted literature
- US20190353666A1 CIRCULATING ANGIOPOIETIN-2 (ANG-2) FOR THE PREDICTION OF RECURRENCE OF ATRIAL FIBRILLATION Public/Granted day:2019-11-21
Information query
IPC分类:
